References
- Bekhit, A. A., Hymete, A., & Asfaw, H. (2012). Evaluation of some 1H-pyrazole derivatives as a dual acting antimalarial and anti-leishmanial agents. Archiv der Pharmazie - Chemistry in Life Sciences, 345(2), 147–154. https://doi.org/https://doi.org/10.1002/ardp.201100078
- Chaudhary, N., & Aparoy, P. (2017). Deciphering the mechanism behind the varied binding activities of COXIBs through molecular dynamic simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies. Journal of Biomolecular Structure & Dynamics, 35(4), 868–882. https://doi.org/https://doi.org/10.1080/07391102.2016.1165736
- Chuang, H. C., Kardosh, A., Gaffney, K. J., Petasis, N. A., & Schönthal, A. H. (2008). COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro. Molecular Cancer, 7, 1–13.
- Dekhane, D. V., Pawar, S. S., Gupta, S., Shingare, M. S., Patil, C. R., & Thore, S. N. (2011). Synthesis and anti-inflammatory activity of some new 4,5-dihydro-1,5-diaryl-1H-pyrazole-3-substituted-heteroazole derivatives. Bioorganic & Medicinal Chemistry Letters, 21(21), 6527–6532. https://doi.org/https://doi.org/10.1016/j.bmcl.2011.08.061
- Dholakia, V., Thakkar, S., Thakkar, A., Doshi, N., & Doshi, H. (2018). Synthesis, characterization, in silico studies and in vitro antibacterial activity of chromene-fused quinoline analogues. Madhav Research & Review, 3(2), 39–44.
- Doshi, H., Bhatt, M., Thakkar, S., & Ray, A. (2012). Synthesis, characterizations and biological screening of tetrahydro-quinazoline analogues. American Journal of Organic Chemistry, 2(5), 122–126. https://doi.org/https://doi.org/10.5923/j.ajoc.20120205.03
- Doshi, H., Thakkar, S., Khirsariya, P., Thakur, M. C., & Ray, A. (2015). 6-Tosyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide analogues: synthesis, characterization, MO calculation, and antibacterial activity. Applied Biochemistry and Biotechnology, 175(3), 1700–1709. https://doi.org/https://doi.org/10.1007/s12010-014-1399-8
- El-Moghazy, S. M., Barsoum, F. F., Abdel-Rahman, H. H., & Marzouk, A. A. (2012). Synthesis and anti-inflammatory activity of some pyrazole derivatives. Medicinal Chemistry Research, 21(8), 1722–1733. https://doi.org/https://doi.org/10.1007/s00044-011-9691-4
- Halgren, T. A. (1999). MMFF VI. MMFF94s option for energy minimization studies. Journal of Computational Chemistry, 20(7), 720–729. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X
- Hassan, G. S., Abdel Rahman, D. E., Abdelmajeed, E. A., Refaey, R. H., Alaraby Salem, M., & Nissan, Y. M. (2019). New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES. European Journal of Medicinal Chemistry, 171, 332–342. https://doi.org/https://doi.org/10.1016/j.ejmech.2019.03.052
- Karad, S. C., Purohit, V. B., Raval, D. K., Kalaria, P. N., Avalani, J. R., Thakor, P., & Thakkar, V. R. (2015). Green synthesis and pharmacological screening of polyhydroquinoline derivatives bearing a fluorinated 5-aryloxypyrazole nucleus. RSC Advances, 5(21), 16000–16009. https://doi.org/https://doi.org/10.1039/C5RA00388A
- Karad, S. D., Purohit, V. B., Thummar, R. P., Vaghasiya, B. K., Kamani, R. D., Thakor, P., Thakkar, V. R., Thakkar, S. S., Ray, A., & Raval, D. K. (2017). Synthesis and biological screening of novel 2-morpholinoquinoline nucleus clubbed with 1,2,4-oxadiazole motifs. European Journal of Medicinal Chemistry, 126, 894–909. https://doi.org/https://doi.org/10.1016/j.ejmech.2016.12.016
- Kardosh, A., Soriano, N., Liu, Y. T., Uddin, J., Petasis, N. A., Hofman, F. M., Chen, T. C., & Schönthal, A. H. (2005). Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib. Blood, 106(13), 4330–4338. https://doi.org/https://doi.org/10.1182/blood-2005-07-2819
- Lee, J. H., Park, H. K., Heo, J., Kim, T., Kim, G. H., Kang, D. H., Song, G. A., Cho, M., Kim, D. S., Kim, H. W., & Lee, C. H. (2008). Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. Journal of Korean Medical Science, 23(3), 521–525. https://doi.org/https://doi.org/10.3346/jkms.2008.23.3.521
- Madhusudana, P., Anuradha, C. M., & Chitta, S. (2017). Design, synthesis, and evaluation of pyrazolo-pyrazole derivatives on Methylisocitratelyase of Pseudomonas aeruginosa: In silico and in vitro study. Journal of Biomolecular Structure and Dynamics, 35(11), 2509–2529. https://doi.org/https://doi.org/10.1080/07391102.2016.1223754
- Malani, K., Thakkar, S. S., Thakur, M. C., Dhandhukia, P., & Doshi, H. V. (2016). Synthesis, characterization and in silico evaluations of diethyl-3-methyl-5-(6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamido) thiophene-2, 4-dicarboxylate analogues as anti-proliferative and anti-microbial agents. World Journal of Pharmaceutical Sciences, 4, 318–330.
- Malani, K., Thakkar, S. S., Thakur, M. C., Ray, A., & Doshi, H. (2016). Synthesis, characterization and in silico designing of diethyl-3-methyl-5-(6-methyl-2-thioxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamido) thiophene-2,4-dicarboxylate derivative as anti-proliferative and anti-microbial agents. Bioorganic Chemistry, 68, 265–274. https://doi.org/https://doi.org/10.1016/j.bioorg.2016.09.001
- Mariappan, G., Saha, B. P., Sutharson, L., Singh, A., Garg, S., Pandey, L., & Kumar, D. (2011). Analgesic, anti-inflammatory, antipyretic and toxicological evaluation of some newer 3-methyl pyrazolone derivatives. Saudi Pharmaceutical Journal, 19(2), 115–122. https://doi.org/https://doi.org/10.1016/j.jsps.2011.01.003
- Mehta, J. V., Gajera, S. B., Thakor, P., Thakkar, V. R., & Patel, M. N. (2015). Synthesis of 1,3,5-trisubstituted pyrazoline derivatives and their applications. RSC Advances, 5(104), 85350–85362. https://doi.org/https://doi.org/10.1039/C5RA17185G
- Mohy El Din, M. M., Senbel, A. M., Bistawroos, A. A., El Mallah, A., Nour El Din, N. A., Bekhit, A. A., & Abd El Razik, H. A. (2011). A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug. Basic & Clinical Pharmacology & Toxicology, 108(4), 263–273. https://doi.org/https://doi.org/10.1111/j.1742-7843.2010.00648.x
- Moodley, I. (2008). Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovascular Journal of Africa, 19, 102–107.
- Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/https://doi.org/10.1002/jcc.21256
- Nitulescu, G. M., Draghici, C., & Olaru, O. T. (2013). New potential antitumor pyrazole derivatives: synthesis and cytotoxic evaluation. International Journal of Molecular Sciences, 14(11), 21805–21818. https://doi.org/https://doi.org/10.3390/ijms141121805
- Ouyang, G., Cai, X. J., Chen, Z., Song, B. A., Bhadury, P. S., Yang, S., Jin, L. H., Xue, W., Hu, D. Y., & Zeng, S. (2008). Synthesis and antiviral activities of pyrazole derivatives containing an oxime moiety. Journal of Agricultural and Food Chemistry, 56(21), 10160–10167. https://doi.org/https://doi.org/10.1021/jf802489e
- Patel, M., Gandhi, P., Thakkar, S., & Doshi, H. (2017). Tetrazolo-quinoxaline analogues as antibacterial agents: Synthesis, characterization and in silico ADMET study. Madhav Research & Review, 3(1), 29–36.
- Pyrko, P., Kardosh, A., Liu, Y. T., Soriano, N., Xiong, W., Chow, R. H., Uddin, J., Petasis, N. A., Mircheff, A. K., Farley, R. A., Louie, S. G., Chen, T. C., & Schönthal, A. H. (2007). Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib. Molecular Cancer Therapeutics, 6(4), 1262–1275. https://doi.org/https://doi.org/10.1158/1535-7163.MCT-06-0629
- Raga, F. A., Gawad, N. M., Georgey, H. H., & Said, M. F. (2013). Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents. European Journal of Medicinal Chemistry, 63, 645–654. https://doi.org/https://doi.org/10.1016/j.ejmech.2013.03.005
- Ramajayam, R., Tan, K. P., Liu, H. G., & Liang, P. H. (2010). Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors. Bioorganic & Medicinal Chemistry, 18(22), 7849–7854. https://doi.org/https://doi.org/10.1016/j.bmc.2010.09.050
- Ranatunge, R. R., Earl, R. A., Garvey, D. S., Janero, D. R., Letts, L. G., Martino, A. M., Murty, M. G., Richardson, S. K., Schwalb, D. J., Young, D. V., & Zemtseva, I. S. (2004). 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: A novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors. Bioorganic & Medicinal Chemistry Letters, 14(24), 6049–6052. https://doi.org/https://doi.org/10.1016/j.bmcl.2004.09.073
- Riyadh, S. M. (2011). Enaminones as building blocks for the synthesis of substituted pyrazoles with antitumor and antimicrobial activities. Molecules, 16(2), 1834–1853. https://doi.org/https://doi.org/10.3390/molecules16021834
- Sakya, S. M., Shavnya, A., Cheng, H., Li, C., Rast, B., Li, J., Koss, D. A., Jaynes, B. H., Mann, D. W., Petras, C. F., Seibel, S. B., Haven, M. L., & Lynch, M. P. (2008). Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition. Bioorganic & Medicinal Chemistry Letters, 18(3), 1042–1045. https://doi.org/https://doi.org/10.1016/j.bmcl.2007.12.025
- Sapariya, N. H., Vaghasiya, B. K., Thummar, R. P., Kamani, R. D., Patel, K. H., Thakor, P., Thakkar, S. S., Ray, A., & Raval, D. K. (2017). Synthesis, characterization, in silico molecular docking study and biological evaluation of a 5-(phenylthio) pyrazole based polyhydroquinoline core moiety. New Journal of Chemistry, 41(19), 10686–10694. https://doi.org/https://doi.org/10.1039/C7NJ01962A
- Schönthal, A. H. (2006). Anti tumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: Implications for glioblastoma therapy. Neurosurgical Focus, 20, 1–10.
- Shrivastava, N., Joshi, J., Sehgal, N., & Kumar, I. P. (2017). Cyclooxygenase-2 identified as a potential target for novel radiomodulator scopolamine methyl bromide: An in silico study. Informatics in Medicine Unlocked, 9, 18–25. https://doi.org/https://doi.org/10.1016/j.imu.2017.05.007
- Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., Burr, A. M., Zhao, W. W., Kent, J. D., Lefkowith, J. B., Verburg, K. M., & Geis, G. S. (2000). Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA, 284(10), 1247–1255. https://doi.org/https://doi.org/10.1001/jama.284.10.1247
- Thakkar, S. S., Thakor, P., Doshi, H., & Ray, A. (2017). 1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities. Bioorganic & Medicinal Chemistry, 25(15), 4064–4075. https://doi.org/https://doi.org/10.1016/j.bmc.2017.05.054
- Thakkar, S. S., Thakor, P., Ray, A., Doshi, H., & Thakkar, V. R. (2017). Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities. Bioorganic & Medicinal Chemistry, 25(20), 5396–5406. https://doi.org/https://doi.org/10.1016/j.bmc.2017.07.057
- Thakor, P., Song, W., Subramanian, R. B., Thakkar, V. R., Vesey, D. A., & Gobe, G. C. (2017). Maslinic acid inhibits proliferation of renal cell carcinoma cell lines and suppresses angiogenesis of endothelial cells. Journal of Kidney Cancer and VHL, 4 (1), 16–24. https://doi.org/https://doi.org/10.15586/jkcvhl.2017.64
- Thakor, P., Subramanian, R. B., Thakkar, S. S., Ray, A., & Thakkar, V. R. (2017). Phytol induces ROS mediated apoptosis by induction of caspase 9 and 3 through activation of TRAIL, FAS and TNF receptors and inhibits tumor progression factor Glucose 6 phosphate dehydrogenase in lung carcinoma cell line (A549). Biomedicine & Pharmacotherapy, 92, 491–500. https://doi.org/https://doi.org/10.1016/j.biopha.2017.05.066
- Thakor, P., Subramanian, R. B., Thakkar, S. S., & Thakkar, V. R. (2020). Cytotoxic, apoptosis inducing effects and anti-cancerous drug candidature of jasmonates. In K. Saravanan, Chukwuebuka Egbuna, Horne Iona Averal, S. Kannan, S. Elavarasi, & Bir Bahadur (Eds.), Drug development for cancer and diabetes (pp. 117–127). Apple Academic Press.
- Tiwari, D., Thakkar, S. S., & Ray, A. (2018). Structure-activity relationship in phenothiazine antipsychotic drugs: Molecular orbital calculation, in silico molecular docking and physico-chemical parameters. Indian Journal of Chemistry - Section B, 57B, 1194–1202.
- Vane, J. R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biology, 231(25), 232–235. https://doi.org/https://doi.org/10.1038/newbio231232a0
- Wolfe, M. M., Lichtenstein, D. R., & Singh, G. (1999). Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. The New England Journal of Medicine, 340(24), 1888–1899. https://doi.org/https://doi.org/10.1056/NEJM199906173402407
- Zhu, J., Song, X., Lin, H. P., Young, D. C., Yan, S., Marquez, V. E., & Chen, C. S. (2002). Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. Journal of the National Cancer Institute, 94(23), 1745–1757. https://doi.org/https://doi.org/10.1093/jnci/94.23.1745